nodes	percent_of_prediction	percent_of_DWPC	metapath
Nevirapine—CYP2A6—lung cancer	0.355	1	CbGaD
Nevirapine—CYP3A5—Gefitinib—lung cancer	0.0294	0.0698	CbGbCtD
Nevirapine—CYP3A5—Teniposide—lung cancer	0.0286	0.0677	CbGbCtD
Nevirapine—CYP2B6—Irinotecan—lung cancer	0.02	0.0473	CbGbCtD
Nevirapine—CYP2C9—Gefitinib—lung cancer	0.0197	0.0468	CbGbCtD
Nevirapine—CYP2C9—Teniposide—lung cancer	0.0192	0.0454	CbGbCtD
Nevirapine—CYP2D6—Gefitinib—lung cancer	0.0181	0.0428	CbGbCtD
Nevirapine—CYP3A5—Crizotinib—lung cancer	0.018	0.0428	CbGbCtD
Nevirapine—CYP3A5—Erlotinib—lung cancer	0.0174	0.0413	CbGbCtD
Nevirapine—CYP2B6—Cisplatin—lung cancer	0.0163	0.0386	CbGbCtD
Nevirapine—CYP3A5—Paclitaxel—lung cancer	0.0159	0.0378	CbGbCtD
Nevirapine—CYP3A5—Irinotecan—lung cancer	0.0157	0.0373	CbGbCtD
Nevirapine—CYP2D6—Vinorelbine—lung cancer	0.0139	0.033	CbGbCtD
Nevirapine—CYP1A2—Erlotinib—lung cancer	0.013	0.0307	CbGbCtD
Nevirapine—CYP3A5—Etoposide—lung cancer	0.0126	0.0298	CbGbCtD
Nevirapine—CYP3A4—Topotecan—lung cancer	0.0126	0.0298	CbGbCtD
Nevirapine—CYP3A5—Docetaxel—lung cancer	0.0115	0.0273	CbGbCtD
Nevirapine—CYP3A4—Gefitinib—lung cancer	0.0115	0.0272	CbGbCtD
Nevirapine—CYP3A4—Teniposide—lung cancer	0.0111	0.0264	CbGbCtD
Nevirapine—CYP2B6—Doxorubicin—lung cancer	0.0109	0.0258	CbGbCtD
Nevirapine—CYP2C9—Paclitaxel—lung cancer	0.0107	0.0253	CbGbCtD
Nevirapine—CYP2D6—Erlotinib—lung cancer	0.0107	0.0253	CbGbCtD
Nevirapine—CYP1A2—Etoposide—lung cancer	0.00937	0.0222	CbGbCtD
Nevirapine—CYP3A4—Vinorelbine—lung cancer	0.00885	0.021	CbGbCtD
Nevirapine—CYP2C9—Cisplatin—lung cancer	0.0086	0.0204	CbGbCtD
Nevirapine—CYP2D6—Vinblastine—lung cancer	0.00857	0.0203	CbGbCtD
Nevirapine—CYP3A4—Crizotinib—lung cancer	0.00704	0.0167	CbGbCtD
Nevirapine—CYP3A4—Erlotinib—lung cancer	0.00679	0.0161	CbGbCtD
Nevirapine—CYP3A4—Paclitaxel—lung cancer	0.00622	0.0147	CbGbCtD
Nevirapine—CYP3A4—Irinotecan—lung cancer	0.00613	0.0145	CbGbCtD
Nevirapine—CYP3A4—Vinblastine—lung cancer	0.00545	0.0129	CbGbCtD
Nevirapine—CYP2D6—Doxorubicin—lung cancer	0.00527	0.0125	CbGbCtD
Nevirapine—CYP3A4—Etoposide—lung cancer	0.00491	0.0116	CbGbCtD
Nevirapine—CYP3A4—Docetaxel—lung cancer	0.00449	0.0106	CbGbCtD
Nevirapine—CYP3A4—Doxorubicin—lung cancer	0.00335	0.00794	CbGbCtD
Nevirapine—Dermatitis—Erlotinib—lung cancer	0.00011	0.000756	CcSEcCtD
Nevirapine—Skin disorder—Cisplatin—lung cancer	0.00011	0.000755	CcSEcCtD
Nevirapine—Immune system disorder—Docetaxel—lung cancer	0.000109	0.000752	CcSEcCtD
Nevirapine—Headache—Erlotinib—lung cancer	0.000109	0.000752	CcSEcCtD
Nevirapine—Paraesthesia—Gemcitabine—lung cancer	0.000109	0.000748	CcSEcCtD
Nevirapine—Asthenia—Vinorelbine—lung cancer	0.000108	0.000744	CcSEcCtD
Nevirapine—Decreased appetite—Irinotecan—lung cancer	0.000108	0.000744	CcSEcCtD
Nevirapine—Eosinophilia—Methotrexate—lung cancer	0.000108	0.000742	CcSEcCtD
Nevirapine—Nausea—Vinblastine—lung cancer	0.000108	0.000742	CcSEcCtD
Nevirapine—Somnolence—Gemcitabine—lung cancer	0.000108	0.000741	CcSEcCtD
Nevirapine—Anorexia—Cisplatin—lung cancer	0.000108	0.000741	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Irinotecan—lung cancer	0.000107	0.000739	CcSEcCtD
Nevirapine—Fatigue—Irinotecan—lung cancer	0.000107	0.000738	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	0.000107	0.000737	CcSEcCtD
Nevirapine—Pancreatitis—Methotrexate—lung cancer	0.000107	0.000735	CcSEcCtD
Nevirapine—Pruritus—Vinorelbine—lung cancer	0.000107	0.000734	CcSEcCtD
Nevirapine—Discomfort—Etoposide—lung cancer	0.000107	0.000734	CcSEcCtD
Nevirapine—Pain—Irinotecan—lung cancer	0.000106	0.000732	CcSEcCtD
Nevirapine—Arthralgia—Paclitaxel—lung cancer	0.000106	0.000728	CcSEcCtD
Nevirapine—Myalgia—Paclitaxel—lung cancer	0.000106	0.000728	CcSEcCtD
Nevirapine—Face oedema—Doxorubicin—lung cancer	0.000105	0.000725	CcSEcCtD
Nevirapine—Erythema—Docetaxel—lung cancer	0.000105	0.000725	CcSEcCtD
Nevirapine—Decreased appetite—Gemcitabine—lung cancer	0.000105	0.000725	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.000105	0.000723	CcSEcCtD
Nevirapine—Nausea—Topotecan—lung cancer	0.000105	0.00072	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000105	0.00072	CcSEcCtD
Nevirapine—Discomfort—Paclitaxel—lung cancer	0.000105	0.000719	CcSEcCtD
Nevirapine—Fatigue—Gemcitabine—lung cancer	0.000104	0.000719	CcSEcCtD
Nevirapine—Pain—Gemcitabine—lung cancer	0.000104	0.000713	CcSEcCtD
Nevirapine—Nausea—Erlotinib—lung cancer	0.000104	0.000713	CcSEcCtD
Nevirapine—Anaphylactic shock—Etoposide—lung cancer	0.000103	0.000712	CcSEcCtD
Nevirapine—Diarrhoea—Vinorelbine—lung cancer	0.000103	0.00071	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000103	0.000708	CcSEcCtD
Nevirapine—Feeling abnormal—Irinotecan—lung cancer	0.000102	0.000705	CcSEcCtD
Nevirapine—Neutropenia—Methotrexate—lung cancer	0.000102	0.000701	CcSEcCtD
Nevirapine—Gastrointestinal pain—Irinotecan—lung cancer	0.000102	0.0007	CcSEcCtD
Nevirapine—Oedema—Paclitaxel—lung cancer	0.000101	0.000698	CcSEcCtD
Nevirapine—Anaphylactic shock—Paclitaxel—lung cancer	0.000101	0.000698	CcSEcCtD
Nevirapine—Paraesthesia—Cisplatin—lung cancer	0.000101	0.000698	CcSEcCtD
Nevirapine—Thrombocytopenia—Etoposide—lung cancer	0.000101	0.000697	CcSEcCtD
Nevirapine—Liver function test abnormal—Doxorubicin—lung cancer	0.000101	0.000693	CcSEcCtD
Nevirapine—Skin disorder—Etoposide—lung cancer	0.0001	0.000691	CcSEcCtD
Nevirapine—Feeling abnormal—Gemcitabine—lung cancer	9.98e-05	0.000687	CcSEcCtD
Nevirapine—Nervous system disorder—Paclitaxel—lung cancer	9.94e-05	0.000684	CcSEcCtD
Nevirapine—Thrombocytopenia—Paclitaxel—lung cancer	9.93e-05	0.000683	CcSEcCtD
Nevirapine—Anorexia—Etoposide—lung cancer	9.86e-05	0.000678	CcSEcCtD
Nevirapine—Skin disorder—Paclitaxel—lung cancer	9.85e-05	0.000678	CcSEcCtD
Nevirapine—Abdominal pain—Irinotecan—lung cancer	9.83e-05	0.000676	CcSEcCtD
Nevirapine—Body temperature increased—Irinotecan—lung cancer	9.83e-05	0.000676	CcSEcCtD
Nevirapine—Toxic epidermal necrolysis—Doxorubicin—lung cancer	9.83e-05	0.000676	CcSEcCtD
Nevirapine—Aspartate aminotransferase increased—Doxorubicin—lung cancer	9.83e-05	0.000676	CcSEcCtD
Nevirapine—Decreased appetite—Cisplatin—lung cancer	9.81e-05	0.000675	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Cisplatin—lung cancer	9.75e-05	0.000671	CcSEcCtD
Nevirapine—Anaemia—Docetaxel—lung cancer	9.73e-05	0.00067	CcSEcCtD
Nevirapine—Anorexia—Paclitaxel—lung cancer	9.67e-05	0.000665	CcSEcCtD
Nevirapine—Pain—Cisplatin—lung cancer	9.65e-05	0.000664	CcSEcCtD
Nevirapine—Stevens-Johnson syndrome—Methotrexate—lung cancer	9.63e-05	0.000663	CcSEcCtD
Nevirapine—Alanine aminotransferase increased—Doxorubicin—lung cancer	9.63e-05	0.000662	CcSEcCtD
Nevirapine—Vomiting—Vinorelbine—lung cancer	9.58e-05	0.00066	CcSEcCtD
Nevirapine—Body temperature increased—Gemcitabine—lung cancer	9.57e-05	0.000659	CcSEcCtD
Nevirapine—Renal failure—Methotrexate—lung cancer	9.55e-05	0.000657	CcSEcCtD
Nevirapine—Rash—Vinorelbine—lung cancer	9.5e-05	0.000654	CcSEcCtD
Nevirapine—Dermatitis—Vinorelbine—lung cancer	9.5e-05	0.000654	CcSEcCtD
Nevirapine—Headache—Vinorelbine—lung cancer	9.44e-05	0.00065	CcSEcCtD
Nevirapine—Conjunctivitis—Methotrexate—lung cancer	9.44e-05	0.00065	CcSEcCtD
Nevirapine—Eosinophilia—Doxorubicin—lung cancer	9.34e-05	0.000643	CcSEcCtD
Nevirapine—Feeling abnormal—Cisplatin—lung cancer	9.3e-05	0.00064	CcSEcCtD
Nevirapine—Paraesthesia—Etoposide—lung cancer	9.29e-05	0.000639	CcSEcCtD
Nevirapine—Pancreatitis—Doxorubicin—lung cancer	9.25e-05	0.000636	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Paclitaxel—lung cancer	9.24e-05	0.000636	CcSEcCtD
Nevirapine—Somnolence—Etoposide—lung cancer	9.19e-05	0.000633	CcSEcCtD
Nevirapine—Hepatobiliary disease—Methotrexate—lung cancer	9.19e-05	0.000632	CcSEcCtD
Nevirapine—Hypersensitivity—Irinotecan—lung cancer	9.16e-05	0.00063	CcSEcCtD
Nevirapine—Paraesthesia—Paclitaxel—lung cancer	9.1e-05	0.000627	CcSEcCtD
Nevirapine—Agranulocytosis—Methotrexate—lung cancer	9.06e-05	0.000624	CcSEcCtD
Nevirapine—Somnolence—Paclitaxel—lung cancer	9.01e-05	0.00062	CcSEcCtD
Nevirapine—Decreased appetite—Etoposide—lung cancer	8.99e-05	0.000619	CcSEcCtD
Nevirapine—Arthralgia—Docetaxel—lung cancer	8.97e-05	0.000617	CcSEcCtD
Nevirapine—Myalgia—Docetaxel—lung cancer	8.97e-05	0.000617	CcSEcCtD
Nevirapine—Nausea—Vinorelbine—lung cancer	8.95e-05	0.000616	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Etoposide—lung cancer	8.93e-05	0.000614	CcSEcCtD
Nevirapine—Body temperature increased—Cisplatin—lung cancer	8.92e-05	0.000614	CcSEcCtD
Nevirapine—Asthenia—Irinotecan—lung cancer	8.92e-05	0.000614	CcSEcCtD
Nevirapine—Fatigue—Etoposide—lung cancer	8.92e-05	0.000614	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	8.9e-05	0.000613	CcSEcCtD
Nevirapine—Pain—Etoposide—lung cancer	8.84e-05	0.000609	CcSEcCtD
Nevirapine—Neutropenia—Doxorubicin—lung cancer	8.82e-05	0.000607	CcSEcCtD
Nevirapine—Decreased appetite—Paclitaxel—lung cancer	8.81e-05	0.000607	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Paclitaxel—lung cancer	8.75e-05	0.000602	CcSEcCtD
Nevirapine—Fatigue—Paclitaxel—lung cancer	8.74e-05	0.000602	CcSEcCtD
Nevirapine—Hepatitis—Methotrexate—lung cancer	8.72e-05	0.0006	CcSEcCtD
Nevirapine—Asthenia—Gemcitabine—lung cancer	8.69e-05	0.000598	CcSEcCtD
Nevirapine—Pain—Paclitaxel—lung cancer	8.67e-05	0.000597	CcSEcCtD
Nevirapine—Anaphylactic shock—Docetaxel—lung cancer	8.59e-05	0.000591	CcSEcCtD
Nevirapine—Oedema—Docetaxel—lung cancer	8.59e-05	0.000591	CcSEcCtD
Nevirapine—Pruritus—Gemcitabine—lung cancer	8.57e-05	0.00059	CcSEcCtD
Nevirapine—Feeling abnormal—Etoposide—lung cancer	8.52e-05	0.000586	CcSEcCtD
Nevirapine—Hyperglycaemia—Doxorubicin—lung cancer	8.51e-05	0.000586	CcSEcCtD
Nevirapine—Diarrhoea—Irinotecan—lung cancer	8.51e-05	0.000585	CcSEcCtD
Nevirapine—Gastrointestinal pain—Etoposide—lung cancer	8.46e-05	0.000582	CcSEcCtD
Nevirapine—Nervous system disorder—Docetaxel—lung cancer	8.43e-05	0.00058	CcSEcCtD
Nevirapine—Thrombocytopenia—Docetaxel—lung cancer	8.41e-05	0.000579	CcSEcCtD
Nevirapine—Feeling abnormal—Paclitaxel—lung cancer	8.36e-05	0.000575	CcSEcCtD
Nevirapine—Skin disorder—Docetaxel—lung cancer	8.35e-05	0.000575	CcSEcCtD
Nevirapine—Stevens-Johnson syndrome—Doxorubicin—lung cancer	8.34e-05	0.000574	CcSEcCtD
Nevirapine—Hypersensitivity—Cisplatin—lung cancer	8.32e-05	0.000572	CcSEcCtD
Nevirapine—Gastrointestinal pain—Paclitaxel—lung cancer	8.29e-05	0.000571	CcSEcCtD
Nevirapine—Diarrhoea—Gemcitabine—lung cancer	8.29e-05	0.00057	CcSEcCtD
Nevirapine—Renal failure—Doxorubicin—lung cancer	8.27e-05	0.000569	CcSEcCtD
Nevirapine—Erythema multiforme—Methotrexate—lung cancer	8.24e-05	0.000567	CcSEcCtD
Nevirapine—Neuropathy peripheral—Doxorubicin—lung cancer	8.24e-05	0.000567	CcSEcCtD
Nevirapine—Urticaria—Etoposide—lung cancer	8.22e-05	0.000565	CcSEcCtD
Nevirapine—Jaundice—Doxorubicin—lung cancer	8.2e-05	0.000564	CcSEcCtD
Nevirapine—Anorexia—Docetaxel—lung cancer	8.19e-05	0.000564	CcSEcCtD
Nevirapine—Abdominal pain—Etoposide—lung cancer	8.18e-05	0.000563	CcSEcCtD
Nevirapine—Body temperature increased—Etoposide—lung cancer	8.18e-05	0.000563	CcSEcCtD
Nevirapine—Conjunctivitis—Doxorubicin—lung cancer	8.17e-05	0.000563	CcSEcCtD
Nevirapine—Asthenia—Cisplatin—lung cancer	8.1e-05	0.000557	CcSEcCtD
Nevirapine—Urticaria—Paclitaxel—lung cancer	8.06e-05	0.000554	CcSEcCtD
Nevirapine—Abdominal pain—Paclitaxel—lung cancer	8.02e-05	0.000552	CcSEcCtD
Nevirapine—Body temperature increased—Paclitaxel—lung cancer	8.02e-05	0.000552	CcSEcCtD
Nevirapine—Hepatobiliary disease—Doxorubicin—lung cancer	7.95e-05	0.000547	CcSEcCtD
Nevirapine—Vomiting—Irinotecan—lung cancer	7.9e-05	0.000544	CcSEcCtD
Nevirapine—Immune system disorder—Methotrexate—lung cancer	7.88e-05	0.000542	CcSEcCtD
Nevirapine—Agranulocytosis—Doxorubicin—lung cancer	7.85e-05	0.00054	CcSEcCtD
Nevirapine—Rash—Irinotecan—lung cancer	7.84e-05	0.000539	CcSEcCtD
Nevirapine—Dermatitis—Irinotecan—lung cancer	7.83e-05	0.000539	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Docetaxel—lung cancer	7.83e-05	0.000539	CcSEcCtD
Nevirapine—Headache—Irinotecan—lung cancer	7.79e-05	0.000536	CcSEcCtD
Nevirapine—Diarrhoea—Cisplatin—lung cancer	7.72e-05	0.000532	CcSEcCtD
Nevirapine—Paraesthesia—Docetaxel—lung cancer	7.72e-05	0.000531	CcSEcCtD
Nevirapine—Vomiting—Gemcitabine—lung cancer	7.7e-05	0.00053	CcSEcCtD
Nevirapine—Somnolence—Docetaxel—lung cancer	7.64e-05	0.000526	CcSEcCtD
Nevirapine—Rash—Gemcitabine—lung cancer	7.64e-05	0.000526	CcSEcCtD
Nevirapine—Dermatitis—Gemcitabine—lung cancer	7.63e-05	0.000525	CcSEcCtD
Nevirapine—Hypersensitivity—Etoposide—lung cancer	7.62e-05	0.000524	CcSEcCtD
Nevirapine—Erythema—Methotrexate—lung cancer	7.59e-05	0.000522	CcSEcCtD
Nevirapine—Headache—Gemcitabine—lung cancer	7.59e-05	0.000522	CcSEcCtD
Nevirapine—Hepatitis—Doxorubicin—lung cancer	7.55e-05	0.00052	CcSEcCtD
Nevirapine—Decreased appetite—Docetaxel—lung cancer	7.47e-05	0.000514	CcSEcCtD
Nevirapine—Hypersensitivity—Paclitaxel—lung cancer	7.47e-05	0.000514	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Docetaxel—lung cancer	7.42e-05	0.000511	CcSEcCtD
Nevirapine—Asthenia—Etoposide—lung cancer	7.42e-05	0.000511	CcSEcCtD
Nevirapine—Connective tissue disorder—Doxorubicin—lung cancer	7.42e-05	0.000511	CcSEcCtD
Nevirapine—Fatigue—Docetaxel—lung cancer	7.41e-05	0.00051	CcSEcCtD
Nevirapine—Nausea—Irinotecan—lung cancer	7.38e-05	0.000508	CcSEcCtD
Nevirapine—Pain—Docetaxel—lung cancer	7.35e-05	0.000506	CcSEcCtD
Nevirapine—Pruritus—Etoposide—lung cancer	7.32e-05	0.000504	CcSEcCtD
Nevirapine—Asthenia—Paclitaxel—lung cancer	7.27e-05	0.000501	CcSEcCtD
Nevirapine—Nausea—Gemcitabine—lung cancer	7.19e-05	0.000495	CcSEcCtD
Nevirapine—Vomiting—Cisplatin—lung cancer	7.18e-05	0.000494	CcSEcCtD
Nevirapine—Pruritus—Paclitaxel—lung cancer	7.17e-05	0.000494	CcSEcCtD
Nevirapine—Erythema multiforme—Doxorubicin—lung cancer	7.14e-05	0.000491	CcSEcCtD
Nevirapine—Rash—Cisplatin—lung cancer	7.12e-05	0.00049	CcSEcCtD
Nevirapine—Dermatitis—Cisplatin—lung cancer	7.11e-05	0.000489	CcSEcCtD
Nevirapine—Feeling abnormal—Docetaxel—lung cancer	7.08e-05	0.000487	CcSEcCtD
Nevirapine—Diarrhoea—Etoposide—lung cancer	7.08e-05	0.000487	CcSEcCtD
Nevirapine—Ill-defined disorder—Methotrexate—lung cancer	7.04e-05	0.000485	CcSEcCtD
Nevirapine—Gastrointestinal pain—Docetaxel—lung cancer	7.03e-05	0.000484	CcSEcCtD
Nevirapine—Anaemia—Methotrexate—lung cancer	7.02e-05	0.000483	CcSEcCtD
Nevirapine—Diarrhoea—Paclitaxel—lung cancer	6.94e-05	0.000477	CcSEcCtD
Nevirapine—Malaise—Methotrexate—lung cancer	6.84e-05	0.000471	CcSEcCtD
Nevirapine—Immune system disorder—Doxorubicin—lung cancer	6.82e-05	0.000469	CcSEcCtD
Nevirapine—Body temperature increased—Docetaxel—lung cancer	6.79e-05	0.000468	CcSEcCtD
Nevirapine—Abdominal pain—Docetaxel—lung cancer	6.79e-05	0.000468	CcSEcCtD
Nevirapine—Nausea—Cisplatin—lung cancer	6.71e-05	0.000461	CcSEcCtD
Nevirapine—Vomiting—Etoposide—lung cancer	6.58e-05	0.000453	CcSEcCtD
Nevirapine—Erythema—Doxorubicin—lung cancer	6.57e-05	0.000452	CcSEcCtD
Nevirapine—Rash—Etoposide—lung cancer	6.52e-05	0.000449	CcSEcCtD
Nevirapine—Dermatitis—Etoposide—lung cancer	6.51e-05	0.000448	CcSEcCtD
Nevirapine—Headache—Etoposide—lung cancer	6.48e-05	0.000446	CcSEcCtD
Nevirapine—Myalgia—Methotrexate—lung cancer	6.46e-05	0.000445	CcSEcCtD
Nevirapine—Arthralgia—Methotrexate—lung cancer	6.46e-05	0.000445	CcSEcCtD
Nevirapine—Vomiting—Paclitaxel—lung cancer	6.45e-05	0.000444	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	6.42e-05	0.000442	CcSEcCtD
Nevirapine—Rash—Paclitaxel—lung cancer	6.39e-05	0.00044	CcSEcCtD
Nevirapine—Dermatitis—Paclitaxel—lung cancer	6.39e-05	0.00044	CcSEcCtD
Nevirapine—Discomfort—Methotrexate—lung cancer	6.38e-05	0.000439	CcSEcCtD
Nevirapine—Headache—Paclitaxel—lung cancer	6.35e-05	0.000437	CcSEcCtD
Nevirapine—Hypersensitivity—Docetaxel—lung cancer	6.33e-05	0.000436	CcSEcCtD
Nevirapine—Anaphylactic shock—Methotrexate—lung cancer	6.19e-05	0.000426	CcSEcCtD
Nevirapine—Asthenia—Docetaxel—lung cancer	6.17e-05	0.000424	CcSEcCtD
Nevirapine—Nausea—Etoposide—lung cancer	6.14e-05	0.000423	CcSEcCtD
Nevirapine—Ill-defined disorder—Doxorubicin—lung cancer	6.1e-05	0.00042	CcSEcCtD
Nevirapine—Pruritus—Docetaxel—lung cancer	6.08e-05	0.000418	CcSEcCtD
Nevirapine—Nervous system disorder—Methotrexate—lung cancer	6.07e-05	0.000418	CcSEcCtD
Nevirapine—Anaemia—Doxorubicin—lung cancer	6.07e-05	0.000418	CcSEcCtD
Nevirapine—Thrombocytopenia—Methotrexate—lung cancer	6.06e-05	0.000417	CcSEcCtD
Nevirapine—Nausea—Paclitaxel—lung cancer	6.02e-05	0.000415	CcSEcCtD
Nevirapine—Skin disorder—Methotrexate—lung cancer	6.02e-05	0.000414	CcSEcCtD
Nevirapine—Malaise—Doxorubicin—lung cancer	5.93e-05	0.000408	CcSEcCtD
Nevirapine—Anorexia—Methotrexate—lung cancer	5.9e-05	0.000406	CcSEcCtD
Nevirapine—Diarrhoea—Docetaxel—lung cancer	5.88e-05	0.000405	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Methotrexate—lung cancer	5.64e-05	0.000388	CcSEcCtD
Nevirapine—Myalgia—Doxorubicin—lung cancer	5.6e-05	0.000385	CcSEcCtD
Nevirapine—Arthralgia—Doxorubicin—lung cancer	5.6e-05	0.000385	CcSEcCtD
Nevirapine—Paraesthesia—Methotrexate—lung cancer	5.56e-05	0.000383	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	5.56e-05	0.000382	CcSEcCtD
Nevirapine—Discomfort—Doxorubicin—lung cancer	5.53e-05	0.00038	CcSEcCtD
Nevirapine—Somnolence—Methotrexate—lung cancer	5.51e-05	0.000379	CcSEcCtD
Nevirapine—Vomiting—Docetaxel—lung cancer	5.46e-05	0.000376	CcSEcCtD
Nevirapine—Rash—Docetaxel—lung cancer	5.42e-05	0.000373	CcSEcCtD
Nevirapine—Dermatitis—Docetaxel—lung cancer	5.41e-05	0.000373	CcSEcCtD
Nevirapine—Decreased appetite—Methotrexate—lung cancer	5.38e-05	0.000371	CcSEcCtD
Nevirapine—Headache—Docetaxel—lung cancer	5.38e-05	0.000371	CcSEcCtD
Nevirapine—Oedema—Doxorubicin—lung cancer	5.36e-05	0.000369	CcSEcCtD
Nevirapine—Anaphylactic shock—Doxorubicin—lung cancer	5.36e-05	0.000369	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Methotrexate—lung cancer	5.35e-05	0.000368	CcSEcCtD
Nevirapine—Fatigue—Methotrexate—lung cancer	5.34e-05	0.000368	CcSEcCtD
Nevirapine—Pain—Methotrexate—lung cancer	5.3e-05	0.000365	CcSEcCtD
Nevirapine—Nervous system disorder—Doxorubicin—lung cancer	5.26e-05	0.000362	CcSEcCtD
Nevirapine—Thrombocytopenia—Doxorubicin—lung cancer	5.25e-05	0.000361	CcSEcCtD
Nevirapine—Skin disorder—Doxorubicin—lung cancer	5.21e-05	0.000359	CcSEcCtD
Nevirapine—Anorexia—Doxorubicin—lung cancer	5.11e-05	0.000352	CcSEcCtD
Nevirapine—Nausea—Docetaxel—lung cancer	5.1e-05	0.000351	CcSEcCtD
Nevirapine—Feeling abnormal—Methotrexate—lung cancer	5.1e-05	0.000351	CcSEcCtD
Nevirapine—Gastrointestinal pain—Methotrexate—lung cancer	5.07e-05	0.000349	CcSEcCtD
Nevirapine—Urticaria—Methotrexate—lung cancer	4.92e-05	0.000339	CcSEcCtD
Nevirapine—Abdominal pain—Methotrexate—lung cancer	4.9e-05	0.000337	CcSEcCtD
Nevirapine—Body temperature increased—Methotrexate—lung cancer	4.9e-05	0.000337	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Doxorubicin—lung cancer	4.89e-05	0.000336	CcSEcCtD
Nevirapine—Paraesthesia—Doxorubicin—lung cancer	4.82e-05	0.000331	CcSEcCtD
Nevirapine—Somnolence—Doxorubicin—lung cancer	4.77e-05	0.000328	CcSEcCtD
Nevirapine—Decreased appetite—Doxorubicin—lung cancer	4.66e-05	0.000321	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Doxorubicin—lung cancer	4.63e-05	0.000319	CcSEcCtD
Nevirapine—Fatigue—Doxorubicin—lung cancer	4.62e-05	0.000318	CcSEcCtD
Nevirapine—Pain—Doxorubicin—lung cancer	4.59e-05	0.000316	CcSEcCtD
Nevirapine—Hypersensitivity—Methotrexate—lung cancer	4.56e-05	0.000314	CcSEcCtD
Nevirapine—Asthenia—Methotrexate—lung cancer	4.44e-05	0.000306	CcSEcCtD
Nevirapine—Feeling abnormal—Doxorubicin—lung cancer	4.42e-05	0.000304	CcSEcCtD
Nevirapine—Gastrointestinal pain—Doxorubicin—lung cancer	4.39e-05	0.000302	CcSEcCtD
Nevirapine—Pruritus—Methotrexate—lung cancer	4.38e-05	0.000302	CcSEcCtD
Nevirapine—Urticaria—Doxorubicin—lung cancer	4.26e-05	0.000293	CcSEcCtD
Nevirapine—Abdominal pain—Doxorubicin—lung cancer	4.24e-05	0.000292	CcSEcCtD
Nevirapine—Body temperature increased—Doxorubicin—lung cancer	4.24e-05	0.000292	CcSEcCtD
Nevirapine—Diarrhoea—Methotrexate—lung cancer	4.24e-05	0.000292	CcSEcCtD
Nevirapine—Hypersensitivity—Doxorubicin—lung cancer	3.95e-05	0.000272	CcSEcCtD
Nevirapine—Vomiting—Methotrexate—lung cancer	3.94e-05	0.000271	CcSEcCtD
Nevirapine—Rash—Methotrexate—lung cancer	3.91e-05	0.000269	CcSEcCtD
Nevirapine—Dermatitis—Methotrexate—lung cancer	3.9e-05	0.000269	CcSEcCtD
Nevirapine—Headache—Methotrexate—lung cancer	3.88e-05	0.000267	CcSEcCtD
Nevirapine—Asthenia—Doxorubicin—lung cancer	3.85e-05	0.000265	CcSEcCtD
Nevirapine—Pruritus—Doxorubicin—lung cancer	3.79e-05	0.000261	CcSEcCtD
Nevirapine—Nausea—Methotrexate—lung cancer	3.68e-05	0.000253	CcSEcCtD
Nevirapine—Diarrhoea—Doxorubicin—lung cancer	3.67e-05	0.000253	CcSEcCtD
Nevirapine—Vomiting—Doxorubicin—lung cancer	3.41e-05	0.000235	CcSEcCtD
Nevirapine—Rash—Doxorubicin—lung cancer	3.38e-05	0.000233	CcSEcCtD
Nevirapine—Dermatitis—Doxorubicin—lung cancer	3.38e-05	0.000233	CcSEcCtD
Nevirapine—Headache—Doxorubicin—lung cancer	3.36e-05	0.000231	CcSEcCtD
Nevirapine—Nausea—Doxorubicin—lung cancer	3.19e-05	0.000219	CcSEcCtD
Nevirapine—CYP1A2—Metabolism—RRM1—lung cancer	9.99e-06	0.000128	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ABCC3—lung cancer	9.94e-06	0.000127	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—AKR1C1—lung cancer	9.71e-06	0.000125	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—AKR1C1—lung cancer	9.63e-06	0.000123	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—GSTP1—lung cancer	9.61e-06	0.000123	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GSTM2—lung cancer	9.57e-06	0.000123	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CNDP2—lung cancer	9.57e-06	0.000123	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—UGT1A1—lung cancer	9.43e-06	0.000121	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—CYP2E1—lung cancer	9.4e-06	0.000121	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—B4GALT5—lung cancer	9.39e-06	0.00012	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—CAT—lung cancer	9.35e-06	0.00012	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—UGT1A1—lung cancer	9.35e-06	0.00012	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—MTMR3—lung cancer	9.3e-06	0.000119	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—NQO1—lung cancer	9.3e-06	0.000119	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—CYP2E1—lung cancer	9.19e-06	0.000118	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GSTA4—lung cancer	9.14e-06	0.000117	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—ABCB1—lung cancer	9.1e-06	0.000117	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—GNG11—lung cancer	9.09e-06	0.000117	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—NQO1—lung cancer	9.09e-06	0.000117	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PGAM1—lung cancer	9.07e-06	0.000116	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—GNG11—lung cancer	9.01e-06	0.000116	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—lung cancer	8.97e-06	0.000115	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—TYMS—lung cancer	8.93e-06	0.000115	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	8.93e-06	0.000115	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GSTA2—lung cancer	8.9e-06	0.000114	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—GSTM1—lung cancer	8.83e-06	0.000113	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—ALDOA—lung cancer	8.66e-06	0.000111	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CYP2A7—lung cancer	8.65e-06	0.000111	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GSTA1—lung cancer	8.59e-06	0.00011	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ALDOA—lung cancer	8.58e-06	0.00011	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ABCC3—lung cancer	8.49e-06	0.000109	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—SDC4—lung cancer	8.47e-06	0.000109	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—NCOA3—lung cancer	8.4e-06	0.000108	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—STK11—lung cancer	8.38e-06	0.000107	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—CYP1A1—lung cancer	8.37e-06	0.000107	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—NCOA3—lung cancer	8.33e-06	0.000107	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—ERCC2—lung cancer	8.3e-06	0.000106	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—AKR1C1—lung cancer	8.23e-06	0.000105	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—STK11—lung cancer	8.19e-06	0.000105	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	8.19e-06	0.000105	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—ADCY1—lung cancer	8.17e-06	0.000105	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—ABCG2—lung cancer	8.17e-06	0.000105	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ADCY1—lung cancer	8.1e-06	0.000104	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ABCG2—lung cancer	8.1e-06	0.000104	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—ENO2—lung cancer	8.02e-06	0.000103	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—HPGDS—lung cancer	8.02e-06	0.000103	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—UGT1A1—lung cancer	7.99e-06	0.000102	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PPP2R1B—lung cancer	7.97e-06	0.000102	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—HPGDS—lung cancer	7.95e-06	0.000102	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ENO2—lung cancer	7.95e-06	0.000102	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PPP2R1B—lung cancer	7.9e-06	0.000101	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	7.79e-06	9.99e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—GSTT1—lung cancer	7.77e-06	9.97e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—GSTP1—lung cancer	7.75e-06	9.94e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GSTA3—lung cancer	7.71e-06	9.89e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—RRM1—lung cancer	7.71e-06	9.89e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—GSTT1—lung cancer	7.71e-06	9.88e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GNG11—lung cancer	7.7e-06	9.87e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—GCLC—lung cancer	7.69e-06	9.85e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CYP2A6—lung cancer	7.69e-06	9.85e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	7.66e-06	9.82e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—GCLC—lung cancer	7.62e-06	9.77e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CYP2A6—lung cancer	7.62e-06	9.77e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	7.59e-06	9.73e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—GSTP1—lung cancer	7.58e-06	9.72e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—CAT—lung cancer	7.55e-06	9.67e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—CAT—lung cancer	7.37e-06	9.46e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—ABCB1—lung cancer	7.34e-06	9.41e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ALDOA—lung cancer	7.33e-06	9.4e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—ENO1—lung cancer	7.29e-06	9.34e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—B4GALT5—lung cancer	7.25e-06	9.29e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ENO1—lung cancer	7.22e-06	9.26e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—TYMS—lung cancer	7.21e-06	9.24e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	7.2e-06	9.23e-05	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—APOA1—lung cancer	7.18e-06	9.21e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—ABCB1—lung cancer	7.17e-06	9.2e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—GSTM1—lung cancer	7.13e-06	9.14e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—NCOA3—lung cancer	7.12e-06	9.13e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	7.1e-06	9.11e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GSTA4—lung cancer	7.05e-06	9.04e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—TYMS—lung cancer	7.05e-06	9.03e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	7e-06	8.97e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—GSTM1—lung cancer	6.96e-06	8.93e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ABCG2—lung cancer	6.92e-06	8.88e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ADCY1—lung cancer	6.92e-06	8.88e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GSTA2—lung cancer	6.87e-06	8.81e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—HPGDS—lung cancer	6.79e-06	8.71e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ENO2—lung cancer	6.79e-06	8.71e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—CYP1A1—lung cancer	6.75e-06	8.66e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PPP2R1B—lung cancer	6.75e-06	8.65e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—ERCC2—lung cancer	6.7e-06	8.59e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	6.66e-06	8.54e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GSTA1—lung cancer	6.63e-06	8.5e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—CYP1A1—lung cancer	6.6e-06	8.47e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GSTT1—lung cancer	6.59e-06	8.44e-05	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PIK3CG—lung cancer	6.56e-06	8.41e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ABCC3—lung cancer	6.56e-06	8.41e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—ERCC2—lung cancer	6.55e-06	8.4e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CYP2E1—lung cancer	6.53e-06	8.38e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GCLC—lung cancer	6.51e-06	8.35e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CYP2A6—lung cancer	6.51e-06	8.35e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	6.49e-06	8.32e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CYP2E1—lung cancer	6.48e-06	8.31e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—NQO1—lung cancer	6.46e-06	8.28e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—NQO1—lung cancer	6.41e-06	8.21e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—AKR1C1—lung cancer	6.35e-06	8.14e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	6.27e-06	8.04e-05	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—POMC—lung cancer	6.24e-06	8e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	6.21e-06	7.97e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ENO1—lung cancer	6.17e-06	7.91e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—UGT1A1—lung cancer	6.16e-06	7.9e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	6.15e-06	7.88e-05	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—CREBBP—lung cancer	6.08e-06	7.8e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	6.07e-06	7.78e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GNG11—lung cancer	5.94e-06	7.62e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—STK11—lung cancer	5.82e-06	7.47e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—APOA1—lung cancer	5.8e-06	7.43e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—STK11—lung cancer	5.77e-06	7.4e-05	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PIK3CD—lung cancer	5.76e-06	7.39e-05	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—ALB—lung cancer	5.69e-06	7.3e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—APOA1—lung cancer	5.66e-06	7.26e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ALDOA—lung cancer	5.66e-06	7.26e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CYP2E1—lung cancer	5.54e-06	7.1e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—NCOA3—lung cancer	5.49e-06	7.04e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—NQO1—lung cancer	5.47e-06	7.02e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	5.42e-06	6.95e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—GSTP1—lung cancer	5.39e-06	6.91e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	5.36e-06	6.87e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ADCY1—lung cancer	5.34e-06	6.85e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ABCG2—lung cancer	5.34e-06	6.85e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—GSTP1—lung cancer	5.34e-06	6.85e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	5.31e-06	6.81e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PIK3CG—lung cancer	5.29e-06	6.78e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CAT—lung cancer	5.24e-06	6.72e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ENO2—lung cancer	5.24e-06	6.72e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—HPGDS—lung cancer	5.24e-06	6.72e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PPP2R1B—lung cancer	5.21e-06	6.68e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CAT—lung cancer	5.2e-06	6.67e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PIK3CG—lung cancer	5.17e-06	6.63e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	5.17e-06	6.63e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—ABCB1—lung cancer	5.1e-06	6.54e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GSTT1—lung cancer	5.08e-06	6.52e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ABCB1—lung cancer	5.06e-06	6.48e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—POMC—lung cancer	5.04e-06	6.46e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CYP2A6—lung cancer	5.02e-06	6.44e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GCLC—lung cancer	5.02e-06	6.44e-05	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PIK3CB—lung cancer	5.02e-06	6.44e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—TYMS—lung cancer	5.01e-06	6.42e-05	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PTGS2—lung cancer	4.98e-06	6.38e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—TYMS—lung cancer	4.97e-06	6.37e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—GSTM1—lung cancer	4.95e-06	6.35e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—STK11—lung cancer	4.93e-06	6.33e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—POMC—lung cancer	4.92e-06	6.31e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—GSTM1—lung cancer	4.91e-06	6.29e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—CREBBP—lung cancer	4.91e-06	6.29e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—CREBBP—lung cancer	4.79e-06	6.15e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ENO1—lung cancer	4.76e-06	6.11e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CYP1A1—lung cancer	4.69e-06	6.02e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—ERCC2—lung cancer	4.66e-06	5.97e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CYP1A1—lung cancer	4.65e-06	5.97e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PIK3CD—lung cancer	4.65e-06	5.96e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	4.63e-06	5.94e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ERCC2—lung cancer	4.62e-06	5.92e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—ALB—lung cancer	4.59e-06	5.89e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GSTP1—lung cancer	4.57e-06	5.85e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PIK3CD—lung cancer	4.55e-06	5.83e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—ALB—lung cancer	4.49e-06	5.75e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CAT—lung cancer	4.44e-06	5.7e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	4.42e-06	5.66e-05	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PTEN—lung cancer	4.34e-06	5.57e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ABCB1—lung cancer	4.32e-06	5.54e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CYP2E1—lung cancer	4.27e-06	5.48e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—TYMS—lung cancer	4.24e-06	5.44e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—NQO1—lung cancer	4.22e-06	5.42e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GSTM1—lung cancer	4.2e-06	5.38e-05	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—EP300—lung cancer	4.14e-06	5.31e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PIK3CB—lung cancer	4.05e-06	5.2e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—APOA1—lung cancer	4.03e-06	5.16e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PTGS2—lung cancer	4.02e-06	5.15e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—APOA1—lung cancer	3.99e-06	5.12e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CYP1A1—lung cancer	3.98e-06	5.1e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PIK3CB—lung cancer	3.96e-06	5.08e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ERCC2—lung cancer	3.94e-06	5.06e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PTGS2—lung cancer	3.93e-06	5.03e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.82e-06	4.9e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—STK11—lung cancer	3.81e-06	4.88e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PIK3CG—lung cancer	3.68e-06	4.71e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PIK3CG—lung cancer	3.65e-06	4.67e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GSTP1—lung cancer	3.52e-06	4.52e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PTEN—lung cancer	3.5e-06	4.49e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—POMC—lung cancer	3.5e-06	4.49e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—POMC—lung cancer	3.47e-06	4.45e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CAT—lung cancer	3.43e-06	4.4e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PTEN—lung cancer	3.42e-06	4.39e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—APOA1—lung cancer	3.41e-06	4.37e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CREBBP—lung cancer	3.41e-06	4.37e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CREBBP—lung cancer	3.38e-06	4.33e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—EP300—lung cancer	3.34e-06	4.28e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ABCB1—lung cancer	3.34e-06	4.28e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—TYMS—lung cancer	3.28e-06	4.2e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.27e-06	4.19e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—EP300—lung cancer	3.27e-06	4.19e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GSTM1—lung cancer	3.24e-06	4.15e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PIK3CD—lung cancer	3.23e-06	4.14e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PIK3CD—lung cancer	3.2e-06	4.11e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—ALB—lung cancer	3.19e-06	4.09e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ALB—lung cancer	3.16e-06	4.06e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PIK3CG—lung cancer	3.12e-06	3.99e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CYP1A1—lung cancer	3.07e-06	3.94e-05	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PIK3CA—lung cancer	3.06e-06	3.93e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ERCC2—lung cancer	3.04e-06	3.9e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—POMC—lung cancer	2.97e-06	3.8e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CREBBP—lung cancer	2.89e-06	3.7e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PIK3CB—lung cancer	2.82e-06	3.61e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PIK3CB—lung cancer	2.79e-06	3.58e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PTGS2—lung cancer	2.79e-06	3.58e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PTGS2—lung cancer	2.77e-06	3.55e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PIK3CD—lung cancer	2.74e-06	3.51e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ALB—lung cancer	2.7e-06	3.47e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—APOA1—lung cancer	2.63e-06	3.38e-05	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—AKT1—lung cancer	2.5e-06	3.21e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PIK3CA—lung cancer	2.47e-06	3.17e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PTEN—lung cancer	2.43e-06	3.12e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PIK3CA—lung cancer	2.42e-06	3.1e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PTEN—lung cancer	2.41e-06	3.09e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PIK3CG—lung cancer	2.4e-06	3.08e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PIK3CB—lung cancer	2.39e-06	3.06e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PTGS2—lung cancer	2.37e-06	3.03e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—EP300—lung cancer	2.32e-06	2.98e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—EP300—lung cancer	2.3e-06	2.95e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—POMC—lung cancer	2.29e-06	2.93e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CREBBP—lung cancer	2.23e-06	2.86e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PIK3CD—lung cancer	2.11e-06	2.71e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ALB—lung cancer	2.09e-06	2.68e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PTEN—lung cancer	2.06e-06	2.64e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—AKT1—lung cancer	2.02e-06	2.59e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—AKT1—lung cancer	1.97e-06	2.53e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—EP300—lung cancer	1.97e-06	2.52e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PIK3CB—lung cancer	1.84e-06	2.36e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PTGS2—lung cancer	1.83e-06	2.34e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PIK3CA—lung cancer	1.72e-06	2.2e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PIK3CA—lung cancer	1.7e-06	2.18e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PTEN—lung cancer	1.59e-06	2.04e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—EP300—lung cancer	1.52e-06	1.95e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PIK3CA—lung cancer	1.46e-06	1.87e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—AKT1—lung cancer	1.4e-06	1.8e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—AKT1—lung cancer	1.39e-06	1.78e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—AKT1—lung cancer	1.19e-06	1.52e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PIK3CA—lung cancer	1.12e-06	1.44e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—AKT1—lung cancer	9.17e-07	1.18e-05	CbGpPWpGaD
